Literature DB >> 29143741

Eliminating viral hepatitis: time to match visions with action.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29143741     DOI: 10.1016/S0140-6736(17)32856-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.

Authors:  Jeffrey V Lazarus; Samya R Stumo; Magdalena Harris; Greet Hendrickx; Kristina L Hetherington; Mojca Maticic; Marie Jauffret-Roustide; Joan Tallada; Kaarlo Simojoki; Tatjana Reic; Kelly Safreed-Harmon
Journal:  J Int AIDS Soc       Date:  2018-04       Impact factor: 5.396

2.  Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example.

Authors:  Ibrahim Altraif
Journal:  Saudi Med J       Date:  2018-08       Impact factor: 1.484

3.  Immune Enhancement by the Tetra-Peptide Hydrogel as a Promising Adjuvant for an H7N9 Vaccine against Highly Pathogenic H7N9 Virus.

Authors:  Xiaoxin Wu; Songjia Tang; Zhehua Wang; Xiaoyun Ma; Lingjian Zhang; Fen Zhang; Lanlan Xiao; Shuai Zhao; Qian Li; Ying Wang; Qingjing Wang; Keda Chen
Journal:  Vaccines (Basel)       Date:  2022-01-17

4.  The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis B.

Authors:  John R Williams; Piero Manfredi; Alessia Melegaro
Journal:  BMC Med       Date:  2018-07-25       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.